{
  "id": 7101182,
  "title": "Jim Cramer Explains Why He Added Hinge Health (HNGE) to His Fantasy Lineup",
  "url": "https://urgent.news/2026/09/12/jim-cramer-explains-why-he-added-hinge-health-hnge-to-his-fantasy",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-12T11:01:30.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/healthcare/articles/jim-cramer-explains-why-added-110130547.html"
  },
  "original_language": "en",
  "account": "Jim Cramer added Hinge Health (HNGE) to his fantasy stock lineup on Mad Money's episode aired on September 8. He explained that Hinge Health is a hybrid medical technology company, acting as a tight end position in the fantasy stock football portfolio. The company, which came public last year, has seen a major breakout, more than tripling from its February lows. Hinge Health provides telemedicine services for musculoskeletal issues, offering an affordable and convenient alternative to traditional physical therapy. Employers and managed care companies pay for the service, benefiting both the employees and the providers.\n\nCramer compared Hinge Health to Indianapolis Colts tight end Tyler Warren, both being second-year players who made significant strides in their respective second seasons. Hinge Health's virtual platform enables companies to handle joint and muscle care for employees more efficiently and cost-effectively.\n\nIn Q2 2026, Hinge Health's revenue grew by 53% year-over-year to $212.8 million. Management raised its full-year revenue guidance to between $856 million and $860 million, reflecting a 46% growth. The company also posted a non-GAAP operating margin of 29% and reported almost $100 million in free cash flow. Despite its substantial stock price surge since February, Hinge Health trades at a forward price-to-earnings multiple of roughly 32x.\n\nHinge Health faces some challenges, including potential economic downturns, integration hurdles with its recent acquisition of Cylinder Health, and rising competition in virtual specialty care. However, the company remains profitable and is held by 48 hedge funds in both Q1 and Q2, with Divisadero Street Capital and Walleye Capital being among the notable investors.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}